• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管细胞癌和肝细胞癌:超声造影的鉴别诊断。

Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.

机构信息

Department of Medical Ultrasonics, The First Affiliated Hospital, Institute of Diagnostic and Interventional Ultrasound, Sun Yat-Sen University, 58 Zhongshan Road 2, Guangzhou 510080, China.

出版信息

Eur Radiol. 2010 Mar;20(3):743-53. doi: 10.1007/s00330-009-1599-8. Epub 2009 Sep 4.

DOI:10.1007/s00330-009-1599-8
PMID:19760416
Abstract

OBJECTIVE

We assessed the usefulness of contrast-enhanced ultrasound (CEUS) in the differentiation of intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC).

METHODS

The CEUS enhancement patterns of 50 ICCs were retrospectively analysed and compared with 50 HCCs. Two readers independently reviewed the baseline ultrasound (BUS) and CEUS images and the diagnostic performances were evaluated by receiver operating characteristic (ROC) analysis. Time-intensity curves (TIC) were plotted for quantification analysis.

RESULTS

In the arterial phase, peripheral rim-like hyperenhancement, heterogeneous hyperenhancement, homogeneous hyperenhancement and heterogeneous hypoenhancement were found in 25, 10, 3 and 12 of the ICCs versus 2, 29, 19 and 0 of the HCCs (P < 0.001), respectively. The diagnostic performance of both readers in terms of the area under the ROC curve (0.745 vs. 0.933 for reader 1, and 0.803 vs. 0.911 for reader 2), sensitivity (28% vs. 90%, and 44% vs. 82%) and accuracy (64% vs. 90%, and 71% vs. 90%) improved significantly after CEUS (all P < 0.05). The interobserver agreement increased from kappa = 0.575 at BUS to kappa = 0.720 after CEUS. TICs demonstrated that the intensities of the peripheral and central portions of the ICCs were lower than those of HCCs (both P < 0.05).

CONCLUSION

CEUS improves the diagnostic performance significantly in the differentiation between ICC and HCC.

摘要

目的

我们评估了超声造影(CEUS)在鉴别肝内胆管细胞癌(ICC)和肝细胞癌(HCC)中的作用。

方法

回顾性分析了 50 例 ICC 的 CEUS 增强模式,并与 50 例 HCC 进行比较。两位读者分别独立地对基础超声(BUS)和 CEUS 图像进行了复查,并通过接受者操作特征(ROC)分析评估了诊断性能。绘制时间-强度曲线(TIC)进行定量分析。

结果

在动脉期,25 例 ICC 中观察到外周边缘状高增强、异质性高增强、均质性高增强和异质性低增强,而 50 例 HCC 中分别为 2 例、29 例、19 例和 0 例(P<0.001)。两位读者在 ROC 曲线下面积(0.745 与 0.933,对于读者 1;0.803 与 0.911,对于读者 2)、敏感度(28%与 90%,44%与 82%)和准确性(64%与 90%,71%与 90%)方面的诊断性能在 CEUS 后均显著提高(均 P<0.05)。观察者间的一致性从 BUS 时的κ=0.575 增加到 CEUS 后的κ=0.720。TIC 显示,ICC 的外周和中央部分的强度均低于 HCC(均 P<0.05)。

结论

CEUS 显著提高了 ICC 和 HCC 之间的鉴别诊断性能。

相似文献

1
Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.肝内胆管细胞癌和肝细胞癌:超声造影的鉴别诊断。
Eur Radiol. 2010 Mar;20(3):743-53. doi: 10.1007/s00330-009-1599-8. Epub 2009 Sep 4.
2
Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.超声造影在鉴别小(≤3厘米)肝细胞癌与肝内胆管癌中的特征
Medicine (Baltimore). 2018 Oct;97(41):e12781. doi: 10.1097/MD.0000000000012781.
3
Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.超声造影在鉴别肝细胞癌和胆管细胞癌中的应用。
Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.
4
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?增强超声能区分肝内胆管细胞癌和肝细胞癌吗?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
5
Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.在有和无风险因素的患者中鉴别肝内胆管细胞癌和肝细胞癌:对比增强超声肝脏成像报告和数据系统 2017 版 LR-M 标准的评估。
Eur Radiol. 2020 Jan;30(1):461-470. doi: 10.1007/s00330-019-06317-2. Epub 2019 Jul 11.
6
Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.混合型肝细胞胆管细胞癌(双表型)肿瘤:超声造影在诊断中的潜在作用。
AJR Am J Roentgenol. 2017 Oct;209(4):767-774. doi: 10.2214/AJR.16.17513. Epub 2017 Aug 4.
7
Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.动态对比增强超声在非肝硬化肝脏肝细胞癌和肝内胆管细胞癌鉴别诊断中的应用。
Ultrasound Med Biol. 2023 Aug;49(8):1780-1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. Epub 2023 May 6.
8
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
9
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
10
Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.对比增强超声在低分化肝细胞癌与肝内胆管癌鉴别诊断中的应用
J Ultrasound Med. 2022 May;41(5):1213-1225. doi: 10.1002/jum.15812. Epub 2021 Aug 23.

引用本文的文献

1
Management of intrahepatic cholangiocarcinoma: a review for clinicians.肝内胆管癌的管理:临床医生综述
Gastroenterol Rep (Oxf). 2025 Jan 26;13:goaf005. doi: 10.1093/gastro/goaf005. eCollection 2025.
2
Rare infiltrative primary hepatic angiosarcoma: A case report and review of literature.罕见的浸润性原发性肝血管肉瘤:一例报告并文献复习
World J Gastrointest Oncol. 2024 Jul 15;16(7):3341-3349. doi: 10.4251/wjgo.v16.i7.3341.
3
Subtype prediction of intrahepatic cholangiocarcinoma using dynamic contrast-enhanced ultrasound.

本文引用的文献

1
Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.肝内胆管癌的增强模式:超声造影与CT增强扫描的比较
Br J Radiol. 2008 Nov;81(971):881-9. doi: 10.1259/bjr/22318475.
2
Novel advancements in the management of hepatocellular carcinoma in 2008.2008年肝细胞癌管理方面的新进展。
J Hepatol. 2008;48 Suppl 1:S20-37. doi: 10.1016/j.jhep.2008.01.022. Epub 2008 Feb 12.
3
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.
使用动态对比增强超声对肝内胆管癌进行亚型预测。
Insights Imaging. 2024 May 16;15(1):119. doi: 10.1186/s13244-024-01683-y.
4
Comparison contrast-enhanced CT with contrast-enhanced US in diagnosing combined hepatocellular-cholangiocarcinoma: a propensity score-matched study.对比增强CT与对比增强超声在诊断肝细胞胆管癌中的对比:一项倾向评分匹配研究。
Insights Imaging. 2024 Feb 14;15(1):44. doi: 10.1186/s13244-023-01576-6.
5
A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.基于改良对比增强超声 LI-RADS M 标准的多参数肝内胆管细胞癌评分系统,用于鉴别肝内胆管细胞癌与肝细胞癌。
Abdom Radiol (NY). 2024 Feb;49(2):458-470. doi: 10.1007/s00261-023-04114-6. Epub 2024 Jan 16.
6
A nomogram based on ultrasonographic features and clinical indicators for differentiating mass-forming intrahepatic cholangiocarcinoma and liver metastatic colorectal adenocarcinoma.基于超声特征和临床指标的列线图用于鉴别肿块型肝内胆管癌和肝转移性结直肠腺癌
Front Oncol. 2023 Oct 31;13:1245686. doi: 10.3389/fonc.2023.1245686. eCollection 2023.
7
The value of combined ultrasound contrast arthrography and subacromial-subdeltoid bursography for detecting and differentiating the rotator cuff tear subtypes in patients with the uncertain rotator cuff tear.对于肩袖撕裂不确定的患者,联合超声造影关节造影和肩峰下-三角肌下囊造影在检测和区分肩袖撕裂亚型方面的价值。
Eur Radiol. 2024 May;34(5):3503-3512. doi: 10.1007/s00330-023-10183-4. Epub 2023 Oct 19.
8
Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.使用 SonoVue 对比增强超声诊断肝细胞癌:韩国放射学会和韩国腹部放射学会 2023 年指南。
Korean J Radiol. 2023 Jun;24(6):482-497. doi: 10.3348/kjr.2023.0324.
9
Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma.联合肝细胞癌和胆管癌诊断中的非侵入性成像
Abdom Radiol (NY). 2023 Jun;48(6):2019-2037. doi: 10.1007/s00261-023-03879-0. Epub 2023 Mar 24.
10
Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update.胆管癌患者管理的当前指南与共识比较:2022年更新
Intractable Rare Dis Res. 2022 Nov;11(4):161-172. doi: 10.5582/irdr.2022.01109.
超声造影(CEUS)指南及临床实践建议 - 2008年更新版
Ultraschall Med. 2008 Feb;29(1):28-44. doi: 10.1055/s-2007-963785.
4
Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.局灶性结节性增生与肝腺瘤:低机械指数超声造影鉴别诊断
AJR Am J Roentgenol. 2008 Jan;190(1):58-66. doi: 10.2214/AJR.07.2493.
5
Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology.实时超声造影下肝细胞癌增强模式与组织病理学肿瘤细胞分化的相关性
Br J Radiol. 2007 May;80(953):321-30. doi: 10.1259/bjr/54805002. Epub 2006 Sep 27.
6
Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.使用低机械指数模式和六氟化硫填充微泡造影剂的超声造影对肝脏局灶性病变进行特征分析。
J Clin Ultrasound. 2006 Jul-Aug;34(6):261-72. doi: 10.1002/jcu.20234.
7
Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients.利用实时超声造影对肝脏小局灶性病变进行特征分析:200例患者的诊断性能分析
J Ultrasound Med. 2006 Mar;25(3):349-61. doi: 10.7863/jum.2006.25.3.349.
8
Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.低机械指数超声造影联合声诺维在外周胆管癌成像中的应用:初步经验
J Ultrasound Med. 2006 Jan;25(1):23-33. doi: 10.7863/jum.2006.25.1.23.
9
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
10
Cholangiocarcinoma.胆管癌
Lancet. 2005 Oct 8;366(9493):1303-14. doi: 10.1016/S0140-6736(05)67530-7.